These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20125007)

  • 1. Androgens and chronic obstructive pulmonary disease.
    Svartberg J
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):257-61. PubMed ID: 20125007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?
    Velema MS; Kwa BH; de Ronde W
    Curr Opin Pulm Med; 2012 Mar; 18(2):118-24. PubMed ID: 22189453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogonadism in chronic obstructive pulmonary disease: incidence and effects.
    Balasubramanian V; Naing S
    Curr Opin Pulm Med; 2012 Mar; 18(2):112-7. PubMed ID: 22234275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic steroids in COPD: a review and preliminary results of a randomized trial.
    Sharma S; Arneja A; McLean L; Duerksen D; Leslie W; Sciberras D; Lertzman M
    Chron Respir Dis; 2008; 5(3):169-76. PubMed ID: 18684793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic obstructive pulmonary disease: risk and benefit of testosterone therapy].
    Samaras N; Samaras D; Lang PO; Bridevaux PO; Gex G; Janssens JP; Pichard C
    Rev Med Suisse; 2012 Nov; 8(363):2224-7. PubMed ID: 23240298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of long-term conventional treatment for overlap syndrome (obstructive sleep apnea and chronic obstructive pulmonary disease) on concurrent erectile dysfunction.
    Perimenis P; Karkoulias K; Konstantinopoulos A; Alchanatis M; Perimeni PP; Athanasopoulos A; Spyropoulos K
    Respir Med; 2007 Feb; 101(2):210-6. PubMed ID: 16872821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypogonadism and chronic obstructive pulmonary disease].
    Vertkin AL; Morgunov LIu; Shakhmanaev KhA
    Urologiia; 2013; (5):116-8, 120-2. PubMed ID: 24437255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Should older men be treated with testosterone?].
    Svartberg J
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):879-82. PubMed ID: 15815734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease.
    Casaburi R; Bhasin S; Cosentino L; Porszasz J; Somfay A; Lewis MI; Fournier M; Storer TW
    Am J Respir Crit Care Med; 2004 Oct; 170(8):870-8. PubMed ID: 15271690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry.
    O'Shea SD; Taylor NF; Paratz JD
    Arch Phys Med Rehabil; 2007 Jan; 88(1):32-6. PubMed ID: 17207672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
    Tashkin DP
    Curr Opin Pulm Med; 2010 Mar; 16(2):97-105. PubMed ID: 20019615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular electrical stimulation of the lower limbs in patients with chronic obstructive pulmonary disease.
    Vivodtzev I; Lacasse Y; Maltais F
    J Cardiopulm Rehabil Prev; 2008; 28(2):79-91. PubMed ID: 18360183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients.
    Planas M; Alvarez J; García-Peris PA; de la Cuerda C; de Lucas P; Castellà M; Canseco F; Reyes L
    Clin Nutr; 2005 Jun; 24(3):433-41. PubMed ID: 15896431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive pulmonary rehabilitation according to severity of COPD.
    Takigawa N; Tada A; Soda R; Takahashi S; Kawata N; Shibayama T; Matsumoto H; Hamada N; Hirano A; Kimura G; Okada C; Endo S; Yamashita M; Date H; Takahashi K
    Respir Med; 2007 Feb; 101(2):326-32. PubMed ID: 16824743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inspiratory muscle strength in chronic obstructive pulmonary disease depending on disease severity.
    Kabitz HJ; Walterspacher S; Walker D; Windisch W
    Clin Sci (Lond); 2007 Sep; 113(5):243-9. PubMed ID: 17391105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thigh muscle strength and endurance in patients with COPD compared with healthy controls.
    Janaudis-Ferreira T; Wadell K; Sundelin G; Lindström B
    Respir Med; 2006 Aug; 100(8):1451-7. PubMed ID: 16337114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease.
    Broekhuizen R; Wouters EF; Creutzberg EC; Weling-Scheepers CA; Schols AM
    Thorax; 2005 May; 60(5):376-82. PubMed ID: 15860712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory muscle strength and muscle endurance are not affected by acute metabolic acidemia.
    Nizet TA; Heijdra YF; van den Elshout FJ; van de Ven MJ; Bosch FH; Mulder PH; Folgering HT
    Clin Physiol Funct Imaging; 2009 Nov; 29(6):392-9. PubMed ID: 19624691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of cachexia in chronic obstructive pulmonary disease.
    Schols AM; Gosker HR
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):282-7. PubMed ID: 19713853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable?
    Gunen H; Mirici A; Meral M; Akgün M
    Curr Opin Pulm Med; 2009 Mar; 15(2):133-7. PubMed ID: 19532028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.